Brain plaques may explain higher risk of Alzheimer's based on mom's history

Mar 15, 2010
Two views of a composite image of the brains analyzed in the study compare the average increases in amyloid-beta deposits in volunteers with a maternally or paternally inherited risk of Alzheimer's, compared to counterparts with no family history of dementia. Red highlights the regions with more amyloid among 14 volunteers with a maternally inherited risk, while blue shows the regions with more amyloid among 14 volunteers with a paternally inherited risk. Purple denotes higher amyloid deposits in both risk groups. Credit: Lisa Mosconi, Ph.D., Mony J. de Leon, Ed.D.

A family history of Alzheimer's is one of the biggest risk factors for developing the memory-robbing disease, which affects more than 5 million Americans and is the most common form of senile dementia. Now an international collaboration led by NYU Langone Medical Center researchers has found the likely basis for this heightened familial risk—especially from the maternal side.

Aided by a new version of a brain scanning technique, the researchers discovered a far greater number of protein clumps linked to the disease among healthy adult children of parents with Alzheimer's compared to counterparts with no of dementia. The average increase in these clumps, called amyloid-beta plaques, was particularly striking among study volunteers whose mothers had been diagnosed with the disease. The plaques appeared throughout most regions of the brain.

The study examined 42 healthy individuals, including 14 whose mothers had Alzheimer's, 14 whose fathers had Alzheimer's, and 14 counterparts with no family history of the disease. On average, the first group of volunteers showed a 15 percent higher burden of amyloid-beta deposits than those with a paternal family history, and a 20 percent higher burden of the protein clumps than those with no familial risk factors.

The new findings, published in the March 15, 2010, online early edition of , may help explain why a family history is such a big risk factor for the brain disease—individuals with an affected parent have a four- to ten-fold greater risk than those with no family history.

The study was led by Lisa Mosconi, PhD, research assistant professor of psychiatry at NYU Langone, and colleagues at NYU Langone who collaborated with researchers at the University of Turku in Finland and Weill Cornell Medical Center in New York.

"Given that brain pathology begins to accumulate years ahead of memory problems in , our findings are intriguing," says Dr. Mosconi. "There is a great effort underway to find early markers of disease, before symptoms appear, so that therapeutic approaches will one day delay or ultimately prevent this disease."

Two views of a composite image of the brains analyzed in Dr. Mosconi's study highlight the average increase in amyloid-beta deposits among 14 healthy adults with a mother affected by Alzheimer's. Regions in yellow have 4 times more amyloid than the corresponding regions of 14 healthy counterparts with no family history of dementia, while regions in red have twice as much amyloid. Credit: Lisa Mosconi, Ph.D., Mony J. de Leon, Ed.D.

Amyloid plaques are one of the hallmarks of Alzheimer's disease, although not everyone with plaques develops the disease. For many years, amyloid-beta plaques could only be measured in autopsied brains, but methods have recently emerged that allow the plaques to be observed in living brains.

The new study combines positron emission tomography (PET) with a fluorescent dye called Pittsburgh Compound B (PiB) that highlights brain amyloid plaques, enabling researchers to actually see the deposits. The dye attaches to plaques and acts like a temporary beacon to highlight their presence during a PET scan. Dr. Mosconi cautions that her team's imaging technique is a potentially powerful research tool and is not ready for use as a diagnostic tool in the clinic.

Plaques begin forming in the brain when, for unknown reasons, normal amyloid-beta proteins change their shape and structure and begin sticking together. The presence of plaques, however, does not necessarily mean an individual will develop Alzheimer's, and much of the harm may arrive well before the plaques appear—no one can yet say whether they are a cause or a consequence of the disease.

It isn't known why the deposits were more common among children of parents with the disease in the study, but Dr. Mosconi suspects that a genetic mechanism is involved. "At this point, we can only speculate that genes that are transmitted from parents, particularly mothers, to their children lead to amyloid depositions, which increase risk for developing dementia," she says.

Dr. Mosconi and her colleagues hope to follow the study's 42 volunteers and more subjects over time to analyze the link between formation and Alzheimer's. For those who never develop dementia, she likewise hopes to determine what preventive factors may be neutralizing the bad effects of amyloid on the brain.

The scanning technique used in the new study also provides more evidence supporting a maternal family link to Alzheimer's, notes Dr. Mosconi, whose previous studies have shown such an association based on reduced glucose metabolism in the brains of healthy adults whose mothers had the disease.

"This imaging study further anchors the risk for Alzheimer's disease associated with having a mother affected by the disease," says Mony J. de Leon, EdD, professor of psychiatry and Director of the Center for Brain Health at NYU Langone Medical Center, and one of the study's authors.

Explore further: Recorded Ebola deaths top 7,000

Related Stories

A maternal link to Alzheimer's disease

Nov 06, 2007

People who have a mother with Alzheimer’s disease appear to be at higher risk for getting the disease than those individuals whose fathers are afflicted, according to a new study by NYU School of Medicine researchers.

Scientists find new cause of Alzheimer's

Apr 19, 2006

Belgium researchers say they are the first to demonstrate the quantity of amyloid protein in brain cells is a major factor of Alzheimer's disease.

Recommended for you

Recorded Ebola deaths top 7,000

13 hours ago

The worst Ebola outbreak on record has now killed more than 7,000 people, with many of the latest deaths reported in Sierra Leone, the World Health Organization said as United Nations Secretary-General Ban ...

Liberia holds Senate vote amid Ebola fears (Update)

17 hours ago

Health workers manned polling stations across Liberia on Saturday as voters cast their ballots in a twice-delayed Senate election that has been criticized for its potential to spread the deadly Ebola disease.

Evidence-based recs issued for systemic care in psoriasis

Dec 19, 2014

(HealthDay)—For appropriately selected patients with psoriasis, combining biologics with other systemic treatments, including phototherapy, oral medications, or other biologic, may result in greater efficacy ...

Bacteria in caramel apples kills at least four in US

Dec 19, 2014

A listeria outbreak believed to originate from commercially packaged caramel apples has killed at least four people in the United States and sickened 28 people since November, officials said Friday.

Steroid-based treatment may answer needs of pediatric EoE patients

Dec 19, 2014

A new formulation of oral budesonide suspension, a steroid-based treatment, is safe and effective in treating pediatric patients with eosinophilic esophagitis (EoE), according to a new study in Clinical Gastroenterology and Hepatology, the official clinical practice journal ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.